Procter and Gamble and Syneron Medical Enter Global Exclusive Agreement to Develop and Supply Home-Use Devices to ...

Syneron Medical Ltd. (NASDAQ: ELOS) and The Procter & Gamble Company announced today they signed an exclusive joint development and supply agreement for the commercialization of patented, elos(TM) based, home-use devices and compositions for the enhancement of skin appearance through the treatment of fine lines, wrinkles, age and sun spots and cellulite.
From: biz.yahoo.com